StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$70.80+1.29 (+1.86%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Establishment Labs operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Establishment Labs's operating cash flow for the twelve months ending Sep 30, 2026 was -$13.38M. For fiscal 2025 it was -$50.89M. The highest annual figure on record is -$12.51M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.89M–
FY2024Dec 31, 2024-$58.52M–
FY2023Dec 31, 2023-$88.51M–
FY2022Dec 31, 2022-$52.17M–
FY2021Dec 31, 2021-$27.53M–
FY2020Dec 31, 2020-$12.51M–
FY2019Dec 31, 2019-$29.98M–
FY2018Dec 31, 2018-$33.89M–
FY2017Dec 31, 2017-$31.97M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$7.70M–
Q2 FY2026Jun 30, 2026-$16.60M–
Q1 FY2026Mar 31, 2026-$4.31M–
Q4 FY2025Dec 31, 2025-$162.00K–
Q3 FY2025Sep 30, 2025-$11.25M–
Q2 FY2025Jun 30, 2025-$18.75M–
Q1 FY2025Mar 31, 2025-$20.73M–
Q4 FY2024Dec 31, 2024-$20.75M–
Q3 FY2024Sep 30, 2024-$12.46M–
Q2 FY2024Jun 30, 2024-$14.15M–
Q1 FY2024Mar 31, 2024-$11.15M–
Q4 FY2023Dec 31, 2023-$8.15M–
Q3 FY2023Sep 30, 2023-$31.51M–
Q2 FY2023Jun 30, 2023-$28.24M–
Q1 FY2023Mar 31, 2023-$20.61M–
Q4 FY2022Dec 31, 2022-$14.02M–
Q3 FY2022Sep 30, 2022-$21.98M–
Q2 FY2022Jun 30, 2022-$11.33M–
Q1 FY2022Mar 31, 2022-$4.84M–
Q4 FY2021Dec 31, 2021-$7.71M-324.5%
Q3 FY2021Sep 30, 2021-$12.46M–
Q2 FY2021Jun 30, 2021-$814.00K–
Q1 FY2021Mar 31, 2021-$6.55M–
Q4 FY2020Dec 31, 2020$3.43M–
Q3 FY2020Sep 30, 2020-$3.05M–
Q2 FY2020Jun 30, 2020-$6.10M–
Q1 FY2020Mar 31, 2020-$6.80M–
Q4 FY2019Dec 31, 2019-$4.03M–
Q3 FY2019Sep 30, 2019-$10.90M–
Q2 FY2019Jun 30, 2019-$7.06M–
Q1 FY2019Mar 31, 2019-$8.00M–
Q4 FY2018Dec 31, 2018-$8.48M–
Q3 FY2018Sep 30, 2018-$10.50M–
Q2 FY2018Jun 30, 2018-$8.98M–
Q1 FY2018Mar 31, 2018-$5.93M–
Q4 FY2017Dec 31, 2017-$8.14M–
Q3 FY2017Sep 30, 2017-$9.03M–

More Establishment Labs figures

See a number that looks wrong?